194 related articles for article (PubMed ID: 2692691)
1. Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid.
McFadden JP; Leonard JN; Powles AV; Rutman AJ; Fry L
Br J Dermatol; 1989 Dec; 121(6):759-62. PubMed ID: 2692691
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.
Rogers RS; Seehafer JR; Perry HO
J Am Acad Dermatol; 1982 Feb; 6(2):215-23. PubMed ID: 7037880
[TBL] [Abstract][Full Text] [Related]
3. Dermatitis herpetiformis exacerbated by indomethacin.
Griffiths CE; Leonard JN; Fry L
Br J Dermatol; 1985 Apr; 112(4):443-5. PubMed ID: 3994920
[TBL] [Abstract][Full Text] [Related]
4. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap.
Wojnarowska F; Marsden RA; Bhogal B; Black MM
J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):792-805. PubMed ID: 3056993
[TBL] [Abstract][Full Text] [Related]
5. Dapsone--other indications.
Barranco VP
Int J Dermatol; 1982 Nov; 21(9):513-4. PubMed ID: 6218128
[No Abstract] [Full Text] [Related]
6. IgA dermatosis in an adult Chinese population. A 10-year study of linear IgA and dermatitis herpetiformis in Singapore.
Ratnam KV
Int J Dermatol; 1988; 27(1):21-4. PubMed ID: 3278990
[TBL] [Abstract][Full Text] [Related]
7. Dapsone as first line therapy for bullous pemphigoid.
Venning VA; Millard PR; Wojnarowska F
Br J Dermatol; 1989 Jan; 120(1):83-92. PubMed ID: 2700666
[TBL] [Abstract][Full Text] [Related]
8. The management of intransigent desquamative gingivitis with Dapsone.
Matthews RW; Pinkney RC; Scully C
Ann Dent; 1989; 48(1):41-3. PubMed ID: 2675748
[TBL] [Abstract][Full Text] [Related]
9. Treatment and management of dermatitis herpetiformis.
Leonard JN; Fry L
Clin Dermatol; 1991; 9(3):403-8. PubMed ID: 1806228
[No Abstract] [Full Text] [Related]
10. Dapsone for the treatment of vesiculo-bullous and pustular diseases.
Piamphongsant T
Int J Dermatol; 1982 Nov; 21(9):512. PubMed ID: 6218127
[No Abstract] [Full Text] [Related]
11. Juvenile blistering diseases: the problems of diagnosis and treatment.
Piamphongsant T; Sirimachan S; Himmunknan P
Asian Pac J Allergy Immunol; 1986 Dec; 4(2):133-7. PubMed ID: 3541947
[TBL] [Abstract][Full Text] [Related]
12. Dapsone and sulfapyridine therapy of pemphigoid diseases.
Rogers RS
Australas J Dermatol; 1986 Aug; 27(2):58-63. PubMed ID: 3555440
[No Abstract] [Full Text] [Related]
13. Linear IgA dapsone responsive bullous dermatosis.
Wojnarowska F
J R Soc Med; 1980 May; 73(5):371-3. PubMed ID: 7017131
[No Abstract] [Full Text] [Related]
14. Polymorphic pemphigoid.
Honeyman JF; Honeyman AR; De la Parra MA; Pinto A; Eguiguren GJ
Arch Dermatol; 1979 Apr; 115(4):423-7. PubMed ID: 373638
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of cicatrical pemphigoid with DDS].
Mashkilleĭson AL; Golousenko IIu; Antonova TN
Vestn Dermatol Venerol; 1984 Oct; (10):37-9. PubMed ID: 6393631
[No Abstract] [Full Text] [Related]
16. Experience with a gluten free diet in the treatment of linear IgA disease.
Leonard JN; Griffiths CE; Powles AV; Haffenden GP; Fry L
Acta Derm Venereol; 1987; 67(2):145-8. PubMed ID: 2438879
[TBL] [Abstract][Full Text] [Related]
17. An analysis of 24 patients with IgA deposition at the BMZ.
Weng MW; Qiu BS; Kang KF
J Dermatol; 1993 May; 20(5):276-8. PubMed ID: 8340531
[TBL] [Abstract][Full Text] [Related]
18. When and how to use sulfones in bullous diseases.
Jablonska S; Chorzelski T
Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048
[No Abstract] [Full Text] [Related]
19. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
Ahmed AR; Colón JE
Arch Dermatol; 2001 Sep; 137(9):1181-9. PubMed ID: 11559214
[TBL] [Abstract][Full Text] [Related]
20. Treatment of subepidermal immunobullous diseases.
Wojnarowska F; Kirtschig G; Khumalo N
Clin Dermatol; 2001; 19(6):768-77. PubMed ID: 11705687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
